Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

During the Trading Day
68.26 +1.25 / +1.87%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
68.16 -0.10 / -0.15%
Volume: 307.8K
Health Technology
Pharmaceuticals: Major

Company Description

Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from biological processes called biologics. The company's biopharmaceutical research and development efforts in the affective (psychiatric) disorders, Alzheimer's/dementia, cardiovascular, diabetes, hepatitis, HIV/Acquired Immunodeficiency Syndrome (AIDS), oncology, immunologic disorders and fibrotic disease areas. Bristol-Myers Squibb was founded in August 1933 and is headquartered in New York, NY.

Contact Information

Bristol-Myers Squibb Co.
345 Park Avenue
New York New York 10154
P:(212) 546-4000
Investor Relations:



Mutual fund holders40.95%
Other institutional33.86%
Individual stakeholders0.31%

Top Executives

Giovanni CaforioChief Executive Officer & Director
Charles A. BancroftChief Financial Officer & Executive Vice President
Paul von AutenriedChief Information Officer & Senior Vice President
Francis M. CussChief Scientific Officer & Executive VP
Carl DeciccoHead-Discovery, Research & Development